Company Reports publications from researchandmarkets.com http://www.researchandmarkets.com en-US Copyright ResearchandMarkets.com 2010 Fri, 10 Sep 2010 20:13:26 GMT Fri, 10 Sep 2010 20:13:26 GMT Research And Markets http://blogs.law.harvard.edu/tech/rss http://www.researchandmarkets.com/rm_images/gif/rm_logo.gif http://www.researchandmarkets.com Research and Markets logo What is Maven: - Largest database of international medical professionals, over 5,600,000 people and over 500,000 medical organisations; - All records are downloadable to excel or inhouse database, with email, postal address and phone contacts; - Profile and segment the entire database using over... http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1208271 press@researchandmarkets.com Company Reports Fri, 26 Mar 2010 14:22:00 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1208271 The Emerging Medical Technologies (EMT) Database is an online tool for strategic marketing, market research, business development and investment executives seeking discreet and detailed business, market, and competitive intelligence on privately-held companies developing disruptive technologies This... http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1205699 press@researchandmarkets.com Company Reports Tue, 02 Mar 2010 12:39:00 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1205699 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the five company over the last years.<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199620 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:17 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199620 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Biogen Idec is a biopharmaceutical company engaged in the process of discovering, developing, manufacturing, and commercializing the therapies in the areas of oncology, neurology and immunology. The company's key products include TYSABRI (natalizumab), AVONEX (Interferon beta-1a), and RITUXAN (rituximab).<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the five company over the last years.<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199619 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:17 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199619 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>AstraZeneca is the second largest pharmaceutical company in the UK. The company was formed in 1999 by the merger of Swedish-based Astra and UK-based Zeneca Group. AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the five company over the last years.<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199618 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:16 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199618 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Amgen is the leading biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics.<br/><br/>The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the five company over the last years.<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199617 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:16 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199617 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Alcon is a research and development driven, global medical specialty company focused on eye care.<br/><br/>It is engaged in the development, manufacture and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products for the treatment of eye disorders.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the five company over the last years.<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199616 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:16 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199616 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Johnson & Johnson (J&J), the world's leading consumer health company, is engaged in the R&D, manufacture and sale of consumer health care products, pharmaceuticals and medical devices and diagnostics. The company has about 250 operating companies in 57 countries. It is headquartered in New Brunswick, New Jersey and employs 118,700 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199615 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:15 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199615 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>CSL is a specialty biopharmaceutical group engaged in developing, manufacturing and marketing of vaccines and plasma protein biotherapies. CSL is headquartered in Victoria, Australia and employs about 9,276 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199614 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:15 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199614 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Celgene, an integrated biopharmaceutical company, discovers, develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company primarily operates in the US. The company is headquartered in Summit, New Jersey and employs 2,441 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199613 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:14 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199613 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>C.R. Bard (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Bard has four major product group categories: vascular, urology, oncology and surgical specialties. It is headquartered in Murray Hill, New Jersey and employs 11,000 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199612 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:14 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199612 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices for application in a range of interventional medical specialties including interventional cardiology, cardiac rhythm management, gynecology and neuromodulation. It is headquartered in Natick, Massachusetts and employs 24,800 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199611 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:14 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199611 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Becton, Dickinson and Company (BD) is a medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents. It is headquartered in Franklin Lakes, New Jersey and employs 28,277 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199610 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:13 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199610 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Beckman Coulter is engaged in the design, manufacture and marketing of biomedical laboratory instruments, software and supplies.The company primarily operates in the US, Europe and Asia Pacific regions. It is headquartered in Fullerton, California and employs about 11,000 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199609 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:13 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199609 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Auxilium Pharmaceuticals (Auxilium) is a specialty biopharmaceutical company engaged in the development and marketing of products to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium is headquartered in Malvern, Pennsylvania and employs 340 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199608 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:13 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199608 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Antares Pharma is a product focused specialty pharmaceutical company engaged in the development, production and marketing of pharmaceutical delivery products, including oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector. It is headquartered in Ewing, New Jersey and employs 24 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199607 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:12 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199607 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease.The company primarily operates in the US and the UK. It is headquartered in Queensbury, New York and employs about 566 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199606 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:12 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199606 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Anesiva is a biopharmaceutical company that develops and commercializes therapeutic treatments for pain management. It offers non-opioid analgesic products and powder intradermal injection systems. The company primarily operates in the US, where it is headquartered in South San Francisco, California and employs around 16 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199605 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:12 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199605 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Anadys Pharmaceuticals (Anadys) is a clinical-stage biopharmaceutical company engaged in the development of novel medicines used in the treatment of hepatitis C and oncology. The company operates primarily in the US, where it is headquartered in San Diego, California and employs 47 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199604 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:11 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199604 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Altus Pharmaceuticals (Altus) is a development stage biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders. The company is headquartered in Cambridge, Massachusetts and employs 145 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199603 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:11 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199603 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Alnylam Pharmaceuticals (Alnylam) is a biopharmaceutical company, that is engaged in discovering, developing, and commercializing microRNA-based therapeutics. The company operates in the US and Germany. It is headquartered in Cambridge, Massachusetts and employs around 170 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199602 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:11 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199602 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Amylin Pharmaceuticals (Amylin) is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and obesity. It has two marketed products in its portfolio, namely, Byetta and Symlin, for the treatment of diabetes.The company is headquartered in San Diego, California.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199601 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:10 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199601 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Alkermes is a biotechnology company that develops products based on sophisticated drug delivery technologies to enhance therapeutic outcomes in major diseases.It is headquartered in Cambridge, Massachusetts and employs about 610 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199600 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:08 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199600 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Alexion Pharmaceuticals (Alexion) is a global biopharmaceutical company that discovers, develops and delivers therapies principally for paroxysmal nocturnal hemoglobinuria (PNH). It is headquartered in Cheshire, Connecticut, and employs around 504 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199599 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:08 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199599 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Affymax is a biopharmaceutical company engaged in developing novel peptide based drugs to improve the treatment of serious and often life-threatening conditions.The company operates in Alto, California. It is headquartered in Alto, California and employs around 147 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199598 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:08 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199598 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>ADVENTRX Pharmaceuticals (ADVENTRX) is a development-stage biopharmaceutical company engaged in in-licensing, developing and commercializing proprietary product candidates for the treatment of cancer.The company primarily operates in the US, where it is headquartered in San Diego, California, and employs around 14 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199597 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:07 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199597 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Adolor Corporation (Adolor) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products.The company is headquartered in Exton, Pennsylvania and employs around 160 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199596 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:07 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199596 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Acorda Therapeutics (Acorda) is a commercial-stage biotechnology company that develops and market therapies to restore function in persons with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the central nervous system (CNS). It is headquartered in Hawthorne, New York, and employs 174 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199595 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:07 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199595 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Achillion Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of infectious diseases such as human immunodeficiency virus (HIV) infection, chronic hepatitis C and resistant bacterial infections. It is headquartered in New Haven, Connecticut and employs 54 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199594 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:06 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199594 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Abbott Laboratories (Abbott), one of the diversified global healthcare companies, is engaged in the discovery, development, manufacture, and sale of pharmaceuticals and medical products. The company sells its products in more than 130 countries.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199593 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:06 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199593 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Alexza Pharmaceuticals (Alexza) is focused on the R&D, and commercialization of novel, proprietary products for the acute treatment of central nervous system (CNS) conditions. The company's product candidates are based on its proprietary technology, the Staccato system. It is headquartered in Mountain View, California.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199592 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:06 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199592 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Genentech, a wholly-owned member of the Roche Group, is one of the leading biotechnology companies. The company is engaged in the discovery, development, manufacture and commercialization of medicines to address significant unmet medical needs. It is headquartered in South San Francisco, California and employs 11,186 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199591 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:06 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199591 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Gedeon Richter is a pharmaceutical company engaged in the research, development and production of pharmaceutical products and is also involved in the wholesale and retail marketing of these products. Gedeon Richter is headquartered in Budapest, Hungary and employs 10, 527 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199590 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:05 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199590 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and central precocious puberty. Endo is headquartered in Chadds Ford, Pennsylvania and employs 1,216 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199589 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:05 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199589 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Cardiome Pharma (Cardiome) develops proprietary drugs to treat and prevent cardiovascular diseases. The company's drug development efforts are focused on the treatment of atrial fibrillation and also on a pre-clinical program directed at improving cardiovascular function. It is headquartered in Vancouver, Canada and employs about 74 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199588 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:05 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199588 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>BTG is a pharmaceuticals company that is involved in the development and commercialization of life science technologies. The company develops products targeting critical care, cancer, neurological and other disorders. It is also involved in the licensing of novel pharmaceuticals and other medical technologies. It is headquartered in London, the UK.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199587 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:05 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199587 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Baxter International (Baxter) is a global diversified healthcare company with expertise in medical devices, pharmaceuticals and biotechnology. The company primarily operates in the US and Europe. It is headquartered in Deerfield, Illinois and employs 48,500 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199586 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:04 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199586 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Antisoma is a biotechnology company specializing in the development of novel drugs for the treatment of cancer. It has a portfolio of drugs in development, including small molecules, antibody-based therapies and a DNA aptamer. The company operates in the UK, the US and Canada. It is headquartered in London, the UK and employs about 71 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199585 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:04 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199585 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. It has operations in Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employs 1,900 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199584 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:03 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199584 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Basilea Pharmaceutica is a biopharmaceutical company focusing on new antibacterial, antifungal and oncology agents to fight drug resistance and on the development of dermatology drugs. It is headquartered in Basel, Switzerland.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199583 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:00 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199583 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Wyeth, which is set to be part of the world's largest pharmaceutical company following the $68-billion merger with Pfizer, is a diversified prescription pharmaceuticals and healthcare products provider. It is headquartered in Madison, New Jersey and employed 47,426 people as of December 2008.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199582 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:00 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199582 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>ViroPharma (the company), is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists, in areas including hospital settings, transplant medicine and gastroenterology. ViroPharma is headquartered in Exton, Pennsylvania and employs 201 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199581 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:15:00 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199581 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Varian Medical Systems (Varian) is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The company primarily operates in the US. The company is headquartered in Palo Alto, California and employs about 4,900 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199580 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:59 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199580 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>United Therapeutics is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic and cardiovascular, and infectious diseases and cancer. The company primarily operates in the US. It is headquartered in Silver Spring, Maryland and employs 360 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199579 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:58 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199579 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>UCB is a global biopharmaceutical company. The company focuses on severe diseases in the fields of central nervous system (CNS) disorders and autoimmune and inflammatory diseases (AIID). It is headquartered in Brussels, Belgium and employs 11,292 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199578 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:58 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199578 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Transcept Pharmaceuticals (TPI), formerly Novacea, is a pharmaceutical company engaged in the development and commercialization of proprietary products for therapeutic needs in the field of neuroscience. The company operates in the US, where it is headquartered in Point Richmond, California and employs around 33 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199577 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:57 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199577 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>SuperGen is a pharmaceutical company engaged primarily to the discovery and development of therapies to treat patients with cancer. The company primarily operates in the US. SuperGen is headquartered in Dublin, California and employs 79 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199576 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:57 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199576 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>St. Jude Medical is engaged in developing, manufacturing and distributing cardiovascular medical devices for the global cardiac rhythm management, cardiology, cardiac surgery and atrial fibrillation therapy areas. It is headquartered in Saint Paul, Minnesota and employs 14,000 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199575 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:56 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199575 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Spectrum Pharmaceuticals is a biopharmaceutical company that acquires, develops and commercializes a portfolio of oncology and other drug candidates. The company primarily operates in US, where it is headquartered in Irvine, California and employs about 84 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199574 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:56 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199574 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Shionogi is a Japan based pharmaceutical company specialized in research, development, manufacturing, and marketing of ethical drugs, over-the-counter (OTC) products and diagnostics. The company primarily operates in Japan, North America and Europe. It is headquartered in Osaka, Japan and employs 5,128 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199573 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:56 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199573 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>NuVasive is engaged in designing, developing and marketing the products for the surgical treatment of spine disorders. The principal products include disruptive surgical platform called Maximum Access Surgery (MAS), cervical and motion preservation products.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199572 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:55 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199572 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Novavax is a clinical stage biopharmaceutical company focused on the development of vaccines against infectious diseases, including H5N1, using proprietary virus-like particle (VLP) technology.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199571 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:55 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199571 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Neurocrine Biosciences (Neurocrine) is a biopharmaceutical company engaged in producing drugs for the treatment of neurological and endocrine related diseases and disorders.<br/><br/>The company's are used for curing diseases and disorders, including insomnia, anxiety, depression, various female and male health disorders, diabetes and other neurological and endocrine related diseases and disorders.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199570 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:54 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199570 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Micromet is a biopharmaceutical company focused on developing of novel, proprietary antibody-based products in the therapeutic areas of cancer, inflammatory and autoimmune diseases.<br/><br/>Its lead product candidate, blinatumomab, is in a Phase II clinical trial for the treatment of patients with acute lymphoblastic leukemia and also in a Phase I clinical trial for the treatment of patients with non-Hodgkin's lymphoma.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199569 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:54 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199569 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Medivation is a biopharmaceutical company that focuses on the development of novel small molecule drugs to treat diseases such as Alzheimer's disease, Huntington's disease and castration-resistant prostate cancer. Its product candidates include Dimebon and MDV3100.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199568 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:53 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199568 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Maxygen is a biotechnology company focused on discovery and development of next generation protein pharmaceuticals for the treatment of disease and serious medical conditions.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199567 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:53 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199567 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Martek Biosciences Corporation (Martek) is engaged in innovation and development of nutritional products. The company develops omega-3 DHA (docosahexaenoic acid) products that promote health and wellness through every stage of life.<br/><br/>It produces life'sDHA, a vegetarian source of the omega-3 fatty acid DHA, for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed; and life'sARA, a vegetarian source of the omega-6 fatty acid ARA (arachidonic acid), for use in infant formula.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199566 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:52 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199566 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Intuitive Surgical is a provider of of robotic-assisted minimally invasive surgery (MIS) products. It develops, manufactures and markets robotic technologies.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199565 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:52 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199565 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Inspire Pharmaceuticals is a biopharmaceutical company that researches, develops and commercializes prescription pharmaceutical products for ophthalmic and pulmonary diseases. The company's products include AzaSite for the treatment of bacterial conjunctivitis; and Elestat for allergic conjunctivitis and royalties.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199564 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:51 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199564 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Infinity Pharmaceuticals (IPI) is engaged in the discovery and development of medicines for the treatment of cancer and related conditions. The company's product pipeline includes retaspimycin, IPI-926 and IPI-493.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199563 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:51 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199563 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Incyte is a drug discovery and development company focused on developing proprietary molecule drugs to treat serious medical needs. The company develops drugs to treat diseases in the areas of oncology, inflammation and diabetes.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199562 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:50 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199562 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>GTx (the company) is a biopharmaceutical company involved in the discovery, development and commercialization of small molecules that target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other medical conditions.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199561 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:50 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199561 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Genomic Health is a life science company that is involved in the development and commercialization of genomic-based clinical laboratory services for cancer treatment.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199560 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:49 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199560 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Flamel Technologies (Flamel) is a biopharmaceutical company principally engaged in the development of polymer-based delivery technologies for medical applications. Its Micropump technology is a controlled release and taste-masking technology for the oral administration of small molecule drugs.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199559 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:49 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199559 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Exelixis is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199558 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:49 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199558 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Chelsea Therapeutics International (CTI) is a biopharmaceutical development stage company that focuses on acquiring and developing products for the treatment of a various human diseases.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199557 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:48 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199557 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Candela Corporation (Candela) manufactures and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199556 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:47 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199556 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Cadence Pharmaceuticals (Cadence) is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199555 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:47 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199555 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>SenoRx develops, manufactures and sells medical devices that are used in the diagnosis of breast cancer. The company develops multiple, proprietary technology platforms and a product portfolio that address the entire range of diagnostic and therapeutic procedures. It is headquartered in Aliso Viejo, California, and employs about 145 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199554 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:46 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199554 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company primarily operates in the US, where it is headquartered in Bothell, Washington and employs around 261 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199553 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:45 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199553 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Schering-Plough, which signed a $41.1 billion merger agreement with its Big Pharma rival Merck & Co. in March 2009, is engaged in the discovery, development and manufacture of human prescription, animal health and consumer health care products. The company is headquartered in Kenilworth, New Jersey and employs 51,000 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199552 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:45 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199552 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Savient Pharmaceuticals (Savient) is a specialty biopharmaceutical company engaged in developing KRYSTEXXA (pegloticase) for the treatment of chronic gout in patients refractory to conventional therapy. The company primarily operates in the US. It is headquartered in East Brunswick, New Jersey and employs 48 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199551 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:44 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199551 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Santarus is a specialty pharmaceutical company engaged in acquiring, developing and commercializing products that address the needs of patients treated by gastroenterologists and other physicians. It primarily operates in the US. The company is headquartered in San Diego, California and employs 345 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199550 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:44 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199550 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Sanofi-Aventis is an international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers pharmaceuticals, vaccines and animal health products. It is headquartered in Paris, France, and employs 98,000 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199549 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:43 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199549 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Recordati markets ethical pharmaceuticals, in-licensed for development and marketing within specific European markets. The company markets its products in more than 100 countries, primarily in the EU. The company is headquartered in Milan, Italy and employs 2,685 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199548 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:43 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199548 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Pfizer is the world's premier biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines for both humans and animals. The company operates in more than 150 countries. It is headquartered in New York City, New York and employs 81,800 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199547 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:42 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199547 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>MorphoSys is a biotechnology company focusing on the development of antibody based products for the pharmaceutical industry. The company primarily operates in Germany, where it is headquartered in Martinsried, Germany and employs about 334 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199546 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:42 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199546 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Merck & Co. which signed the $41.1 billion merger deal with Schering-Plough, is one of the research driven Big Pharma companies. The company is engaged in research, manufacturing and marketing of drugs and pharmaceuticals. Merck & Co. is headquartered in Whitehouse Station, New Jersey and employs 55,200 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199545 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:41 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199545 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Labopharm is an international specialty pharmaceutical company focused on optimizing the performance of existing drugs by incorporating its proprietary, advanced controlled-release technologies. It is headquartered in Quebec, Canada and employs around 168 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199544 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:41 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199544 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>GlaxoSmithKline (GSK) is one of the world's leading research-based pharmaceutical and healthcare companies. GSK is engaged in the discovery, development, manufacturing and marketing of pharmaceutical and consumer health-related products. GSK is headquartered in Brentford, the UK and employs 99,003 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199543 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:40 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199543 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Genmab (the company) is a Denmark-based biotechnology company that develops human antibodies for the treatment of life-threatening and debilitating diseases. It is headquartered in Copenhagen, Denmark and employs 555 people.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199542 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:39 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199542 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Sangamo Biosciences is engaged in the research, development and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification.<br/><br/>The company develops ZFP transcription factors (ZFP TFsTM ) and ZFP nucleases (ZFNsTM) which has a range of applications including human therapeutics, plant agriculture, research reagents and cell-line engineering.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199541 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:39 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199541 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Salix Pharmaceuticals (Salix) is a specialty pharmaceutical company that develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases.<br/><br/>The company's marketed drugs for gastrointestinal disease includes XIFAXAN (rifaximin) tablets 200 mg, OSMOPREP (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, and METOZOLV ODT (metoclopramide HCl).<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199540 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:38 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199540 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>F. Hoffmann-La Roche (Roche) is one of the leading research-focused healthcare groups in the world, specialized in the discovery, development and commercialization of innovative diagnostic and therapeutic products.<br/><br/>The group develops prescription products in several therapeutic areas including oncology, virology, renal anemia, cardiovascular and respiratory diseases.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199539 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:38 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199539 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Carl Zeiss Meditec is one of the leading suppliers of complete ophthalmic systems including IOLs (intraocular lens implants) and disposables and of optical and digital visualization systems for neuro and ENT (ear, nose and throat) surgery.<br/><br/>In the field of ophthalmology, the company offers integrated solutions for treating the four main eye diseases: vision defects (refraction), cataracts, glaucoma and retinal disorders.<br/><br/>In the field of neuro and ENT surgery, the company provides surgical microscopes and microsurgical visualization solutions for a range of applications, such as tumor and vascular surgery in the head region and/or spinal surgery.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199538 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:37 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199538 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>BioMS Medical is a biotechnology company engaged in the investment, development and commercialization of pharmaceutical technologies. The company's main focus is on the development and commercialization of a medical treatment for multiple sclerosis.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199537 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:37 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199537 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Zimmer Holdings (Zimmer) is engaged in designing, developing, manufacturing, and marketing of orthopedic and dental reconstructive implants, spinal implants, trauma products and related orthopedic surgical products. It also offers healthcare related services.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199536 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:36 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199536 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Watson Pharmaceuticals (Watson) is engaged in the development and manufacture of specialty and non-patented pharmaceutical products. The company markets a broad range of generic products for the nephrology, urology, pain management, and therapeutic dermatology markets.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199535 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:35 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199535 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Warner Chilcott is a specialty pharmaceutical company engaged in developing, manufacturing and marketing of branded prescription pharmaceutical products in women's healthcare and dermatology area.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199534 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:34 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199534 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Vertex Pharmaceuticals (Vertex) is a global biotechnology company engaged in discovering, developing and commercializing small molecule drugs for the treatment of major diseases like viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain. The company primarily operates in the US.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199533 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:34 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199533 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Stryker is one of the world's leading medical technology companies engaged in the development, manufacture and marketing of medical devices and instrumentations in the orthopedic as well as other medical specialties.<br/><br/>The company provides products such as implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; surgical equipment; surgical navigation systems; and patient handling and emergency medical equipment.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199532 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:33 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199532 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Smith & Nephew is a global medical devices group engaged in the development, manufacture and marketing of medical devices in the sectors of orthopedic reconstruction, orthopedic trauma and clinical therapies, endoscopy and advanced wound management. Smith & Nephew is the parent company of Smith & Nephew Group.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199531 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:33 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199531 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Qiagen, a Netherlands holding company, is the leading provider of sample and assay technologies for use in sample collection, and nucleic acid and protein handling, separation, and purification. The company offers nearly 500 consumable products and automated solutions. It has operations in more than 40 locations worldwide.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199530 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:32 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199530 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>OSI Pharmaceuticals (OSI Pharma) is a biotechnology company engaged in the discovery, development, and commercialization of drugs for the treatment of oncology, diabetic and obesity.<br/><br/>The company's flagship product, Tarceva, is an oral, once-a-day, small molecule therapeutic designed to inhibit the receptor tyrosine kinase activity of the protein product of the HER1/EGFR gene.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199529 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:32 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199529 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.<br/><br/>Nektar's technology and drug development expertise have enabled nine approved products in the US or Europe for partners, which include leading biopharmaceutical companies, including UCB's Cimzia for rheumatoid arthritis and Crohn's Disease, Roche's PEGASYS for hepatitis C and Amgen's Neulasta for neutropenia.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199528 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:31 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199528 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Momenta Pharmaceuticals (Momenta) is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. It applies its technology to the development of generic versions of complex drug products and novel drugs.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199527 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:31 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199527 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Medtronic is a medical technology company engaged in manufacturing a range of medical devices and therapies. The company operates its business through seven segments that include cardiac rhythm disease management; spinal; cardiovascular; neuromodulation; diabetes; surgical technologies; and physio-control.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199526 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:29 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199526 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>Medicis Pharmaceutical Corporation (Medicis) is an independent specialty pharmaceutical company that primarily focuses on the treatment of dermatological and aesthetic conditions.<br/><br/>It offer a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199525 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:29 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199525 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>MDRNA (formerly Nastech Pharmaceutical) is a biotechnology company engaged in the development and commercialization of therapeutic drugs based on RNA interference (RNAi). The company's R&D activities are focused on the development of viable product candidates in therapeutic areas of oncology, inflammation and metabolic diseases.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199524 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:28 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199524 The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .<br/><br/>Scope<br/><br/><br/>- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation<br/><br/>- Provides key ratios<br/><br/>- Includes information on revenue distribution by business segments and geographies<br/><br/><br/>Highlights of this title<br/><br/>MannKind Corporation (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products for diseases such as diabetes and cancer.<br/><br/>Key reasons to purchase this title<br/><br/><br/>- Access important financial information and analysis on the company in a single datapack<br/><br/>- Understand the financial evolution of the company over the last five years<br/><br/>- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization<br/> http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199523 press@researchandmarkets.com Company Reports Mon, 08 Feb 2010 16:14:28 GMT http://www.researchandmarkets.com/reportinfo.asp?rfm=rss&report_id=1199523